With hypotheses pointing in both directions, whether to remain on an ACE/ARB during the COVID-19 pandemic is a tough call, particularly when there are other MoAs one can use for control of hypertension.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”